Using 18F-FAPI-04 PET imaging for cancer diagnosis and monitoring

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of 18F-FAPI-04 positron emission tomography/computed tomography (PET/CT) and PET/magnetic resonance imaging (PET/MR) in diagnosing primary and metastatic cancer lesions, detecting recurrences, and assessing treatment responses. Patients with various types of malignant tumors will undergo imaging to quantify tumor uptake and compare results against histopathology and follow-up data. The study aims to calculate the sensitivity, specificity, and accuracy of these imaging techniques in a clinical setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion Criteria:

patients with non-malignant lesions; patients with pregnancy; the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Where it's running

• Hunan Cancer hospital
  Changsha, Hunan, China Recruiting

Study contacts

• Study coordinator: Hui Ye, PhD
• Email: yehui@hnca.org.cn
• Phone: 13755117105

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Classifying duodenal polyps in familial adenomatous polyposis

  This project will test two risk models to see if they better predict dangerous duodenal polyps and cancer risk in people with genetically confirmed FAP.

  Recruiting at 2 sites Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Milan, MI and 1 other locations · NCT07199127

• Using a new imaging technique to detect cancer-associated fibroblasts in various cancers

  This study is testing a new imaging method to see if it can better detect certain cancer-related cells in people with newly diagnosed esophageal or pancreatic cancer compared to standard imaging techniques.

  Recruiting at 2 sites Phase 2/3 KU Leuven · Edegem and 2 other locations · NCT06782412

• Using video capsules to examine patients with Lynch Syndrome

  This study is testing whether video capsules can be a good alternative to regular colonoscopies for people with Lynch Syndrome to help improve cancer screening.

  Recruiting Royal Marsden NHS Foundation Trust · London, (Select) · NCT06712095

• Evaluating PSMA PET/CT Imaging for Prostate Cancer Patients

  This study is testing a special type of imaging called PSMA PET/CT to see if it can help find cancer in adults who have or might have prostate cancer.

  Recruiting at 3 sites Tianjin Medical University · Hefei, Anhui and 2 other locations · NCT06690970

• Testing [177Lu]Lu-OncoFAP-23 alone or with L19-IL2 for metastatic FAP-positive solid tumors

  This study will test whether the radioligand [177Lu]Lu-OncoFAP-23, given alone or together with the antibody-cytokine L19-IL2, is safe and shows early benefit in adults with advanced or metastatic FAP-positive solid tumors.

  Recruiting at 2 sites Phase 1 Philogen S.p.A. · Bergamo, Bergamo and 3 other locations · NCT06640413

• Imaging with 68Ga-PSFA in patients with specific cancer markers

  This study is testing a new imaging agent to see if it can help find cancer spots in patients with certain cancer markers.

  Recruiting Early Phase 1 First Affiliated Hospital of Chongqing Medical University · Chongqing, Chongqing Municipality · NCT06387381

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.